BGT vs CUV

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

36LOW

CUV

CLINUVEL FPO [CUV]

61MEDIUM-HIGH

Score Breakdown

BGT CUV
Technical
48
47
Catalyst
50
55
Sentiment
50
50
Fundamental
44
71
Momentum
52
56
Risk Gate
27
40

Key Metrics

BGT Metric CUV
$6.6MMarket Cap$513.9M
754KAvg Volume (20d)122K
N/AShort Interest+9.0%
$0.06152-Week High$14.000
$0.01652-Week Low$8.350
+0.0%Daily Change-1.3%
$0.017Reference Price$10.090
-202.2%ROE+14.0%
N/AProfit Margin+33.8%

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.83, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

CUV Signals

MACD momentum is losing steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Moderate P/S ratio (5.3x)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare BGT and CUV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BGT vs IBX →BGT vs IMM →BGT vs LDX →BGT vs NTI →BGT vs NYR →
BGT Full Analysis → CUV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).